The purpose of this retrospective review was to evaluate SpineJack implantation in cancer-related vertebral compression fractures in 13 consecutive patients (mean age, 62.8 years ± 18.8). A total of 36 devices were inserted at 20 levels (13 [65%] lumbar and 7 [35%] thoracic vertebrae), with a mean Spinal Instability Neoplastic Score of 9.1 ± 2.1. Vertebral height restoration was observed in 10 levels (50%), with a mean height restoration of 5.6 mm ± 2.2 (interquartile range [IQR], 4-7.5). A total of 6 cement leakages were observed in 3 (23%) patients without clinical consequences. No severe adverse events were observed. One adjacent fracture occurred. Average pain scores on the visual analog scale significantly improved from 5.5 ± 1.8 (IQR, 4-7) preoperatively to 1.5 ± 2.2 (IQR, 0-3.3) at 1 month (P < .01) and to 1.5 ± 1.3 (IQR, 0.3-2.8) at 6 months (P < .01). In this small cohort, SpineJack offered pain relief in cancer-related fractures without an observed increase in adverse events.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jvir.2021.10.002 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Osimertinib for Uncommon Endothelial Growth Factor Receptor-Mutant Non-Small Cell Lung Carcinoma: A Case Report.
Case Rep Oncol
November 2024
Division of Hematology and Oncology, Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Article Synopsis
- Non-small cell lung cancer (NSCLC) is the most common lung cancer type, responsible for a majority of cancer deaths globally, and advancements in treatments, especially targeted therapies like osimertinib, have improved management options.
- Osimertinib, a third-generation tyrosine kinase inhibitor, effectively targets specific mutations in the EGFR gene, including rare mutations, as exemplified by a 64-year-old woman whose unique exon 19 mutation responded well to the drug, leading to 26 months of disease control.
- The study highlights the limited research available for rare EGFR mutations and emphasizes the need for further prospective studies to better understand treatment responses and ensure safe and effective therapies for this patient group.
Interventional Radiology Management of Bone Metastasis Pain: Strategies and Techniques.
Cardiovasc Intervent Radiol
November 2024
Department of Diagnostic and Interventional Radiology, Foch Hospital, Suresnes, France.
Osseous metastases are common in cancer patients, and pain is one of the most frequent associated symptoms. The management of cancer-related pain is still problematic worldwide with 40 to 50% of patients still being undertreated. A significant proportion of cancer patients will require discontinuation of traditional analgesic treatments such as opioids due to unsuccessful pain relief or severe unmanageable toxicity and may, therefore, benefit from alternative treatments.
View Article and Find Full Text PDFmay predict poor prognosis of lower-grade glioma patients and be a potential target for immunotherapy.
Cancer Biol Ther
December 2024
Department of Surgery of Spine and Spinal Cord, Henan Provincial People's Hospital, Henan Province Intelligent orthopedic technology innovation and transformation International Joint Laboratory, Henan Key Laboratory for intelligent precision orthopedics, People's Hospital of Zhengzhou University, People's Hospital of Henan University, Zhengzhou, Henan, China.
Article Synopsis
- * Analysis of 1,046 LGG samples revealed that higher DSN1 expression correlates with poorer patient survival, while hypermethylation of DSN1 is associated with longer survival.
- * The study suggests that DSN1 could serve as a diagnostic and prognostic marker for LGG and may be a potential target for future anti-tumor immunotherapy.
Comparing DCE-MRI and DSA: Understanding the embolization of hypervascular spinal metastases.
J Med Imaging Radiat Oncol
November 2024
Baqai Medical University, Karachi, Pakistan.
This study aims to examine and compare the effectiveness of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and Digital Subtraction Angiography (DSA) in evaluating hypervascular spinal metastases. A comprehensive literature review was conducted, utilizing top-tier databases such as PubMed, Scopus and Google Scholar, to compile an authoritative and up-to-date overview of the current advancements in the field. We synthesized key studies focusing on the advantages, limitations and efficacy of both imaging techniques.
View Article and Find Full Text PDFAutonomic dysreflexia in patients with cancer and spinal cord injury: a case series.
Spinal Cord Ser Cases
September 2024
Rehabilitation Medicine Service, Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Introduction: Autonomic dysreflexia (AD) is a potentially life-threatening syndrome that can occur in patients with traumatic injury to the spinal cord; however, it has not been well described in patients with non-traumatic spinal cord injury (SCI) from cancer and its treatments.
Case Presentation: We report four cases of autonomic dysreflexia secondary to primary spinal cord tumors and metastatic disease to the spine, and as sequela to cancer treatment. The clinical characteristics, diagnostic considerations, and therapeutic strategies used to mitigate the symptoms are discussed.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!